Crossmark Global Holdings’s Lydall, Inc. LDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-20,050
Closed -$332K 1452
2020
Q3
$332K Sell
20,050
-1,410
-7% -$24.5K 0.01% 957
2020
Q2
$291K Buy
21,460
+4,810
+29% +$53.2K 0.01% 1027
2020
Q1
$108K Buy
16,650
+630
+4% +$10.3K ﹤0.01% 1166
2019
Q4
$329K Buy
16,020
+2,550
+19% +$52.8K 0.01% 1058
2019
Q3
$336K Sell
13,470
-80
-0.6% -$1.71K 0.01% 1004
2019
Q2
$274K Buy
13,550
+510
+4% +$11.1K 0.01% 1144
2019
Q1
$306K Sell
13,040
-40
-0.3% -$1.01K 0.01% 1108
2018
Q4
$266K Buy
+13,080
New +$357K 0.01% 1148
2017
Q4
Sell
-6,390
Closed -$366K 1683
2017
Q3
$366K Buy
+6,390
New +$319K 0.01% 1174
2016
Q3
$366K Buy
+6,390
New +$299K 0.01% 1174

Other funds holding LDL

Crossmark Global Holdings's LDL Position: Q4 2020 in Review

Crossmark Global Holdings sold out of Lydall, Inc. (LDL) in Q4 2020, closing a stake of 20,050 shares — an estimated $332K sold.

Crossmark Global Holdings first reported a position in LDL in Q3 2016 and held it in 10 quarters. The position peaked at $366K in Q3 2017. 144 funds tracked by Wall St. Rank hold LDL as of Q4 2020.

  • Crossmark Global Holdings reported no remaining Lydall, Inc. position as of Q4 2020 after selling out during the quarter.
  • Crossmark Global Holdings sold 20,050 Lydall, Inc. shares in Q4 2020, an estimated $332K.
  • Crossmark Global Holdings first reported a position in Lydall, Inc. in Q3 2016 and held it in 10 quarters.
  • Crossmark Global Holdings's Lydall, Inc. position peaked at $366K in Q3 2017.
  • 144 funds tracked by Wall St. Rank held Lydall, Inc. as of Q4 2020.

Based on Crossmark Global Holdings's 13F filing for Q4 2020, filed 14 Jan 2021.